Annual Health

 
News Articles for Annual Health top ^
SAN DIEGO, May 2, 2014 (GLOBE NEWSWIRE) -- Tandem Diabetes CareĀ®, Inc. (Nasdaq:TNDM) , a medical device company and manufacturer of the t:slimĀ® Insulin Pump, today announced a schedule change for its presentation at the Deutsche Bank 39th Annual Health Care Conference at the InterContinental Boston Hotel in Boston, Massachusetts.
Sign-up for Tandem Diabetes Care Announces Schedule Change for Deutsche Bank 39th Annual Health Care Conference Presentation investment picks
NEW YORK, May 1, 2014 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI) , a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, will present at the Deutsche Bank 39th Annual Health Care Conference on Thursday, May 8, 2014, at 1:30 P.M. Eastern Time in Boston, MA.
Sign-up for Intra-Cellular Therapies to Present at the Deutsche Bank 39th Annual Health Care Conference investment picks
NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the Deutsche Bank 39th Annual Health Care Conference on Wednesday, May 7, 2014 at 1:30 PM ET.
Sign-up for Stemline Therapeutics to Present at the Deutsche Bank 39th Annual Health Care Conference investment picks
LEXINGTON, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS) , an oncology-focused drug development company seeking to develop novel drug candidates for the treatment of human cancers, today announced that the Company will present at the Deutsche Bank 39 th Annual Health Care Conference at 4:50 p.m. ET on May 7, 2014, in Boston.
Sign-up for Curis to Present at the Deutsche Bank 39th Annual Health Care Conference investment picks
WALTHAM, Mass., May 1, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) announced today that Lonnie Moulder, CEO of TESARO, and Dr.
Sign-up for TESARO to Present at the Deutsche Bank Securities 39th Annual Health Care Conference investment picks
SAN DIEGO, April 30, 2014 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE) , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that Christian Weyer, M.D., M.A.S., President and Chief Executive Officer, will present an overview of the company at the Deutsche Bank 39 th Annual Healthcare Conference in Boston, MA.
Sign-up for Fate Therapeutics to Present at Deutsche Bank 39th Annual Health Care Conference investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Annual Health
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Annual Global  |  Next: Annual Healthcare